nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—Parkinson's disease	0.956	1	CbGaD
Atazanavir—Ritonavir—CYP2E1—Parkinson's disease	0.00302	0.212	CrCbGaD
Atazanavir—Lopinavir—CYP2D6—Parkinson's disease	0.00263	0.185	CrCbGaD
Atazanavir—Ritonavir—CYP2D6—Parkinson's disease	0.00221	0.156	CrCbGaD
Atazanavir—Lopinavir—ABCB1—Parkinson's disease	0.00188	0.132	CrCbGaD
Atazanavir—Saquinavir—CYP2D6—Parkinson's disease	0.00168	0.118	CrCbGaD
Atazanavir—Ritonavir—ABCB1—Parkinson's disease	0.00158	0.111	CrCbGaD
Atazanavir—Saquinavir—ABCB1—Parkinson's disease	0.0012	0.0844	CrCbGaD
Atazanavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00014	0.00472	CbGpPWpGaD
Atazanavir—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000138	0.00466	CbGpPWpGaD
Atazanavir—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000134	0.00452	CbGpPWpGaD
Atazanavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000133	0.0045	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000133	0.0045	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000132	0.00447	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000129	0.00436	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000128	0.00434	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000125	0.00422	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000122	0.00412	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ND3—Parkinson's disease	0.000121	0.00408	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MCCC1—Parkinson's disease	0.000121	0.00408	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000118	0.004	CbGpPWpGaD
Atazanavir—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000117	0.00395	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000117	0.00394	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000115	0.00389	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—OMD—Parkinson's disease	0.000114	0.00384	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TALDO1—Parkinson's disease	0.000114	0.00384	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000112	0.00379	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000112	0.00378	CbGpPWpGaD
Atazanavir—ABCC1—Disease—VPS35—Parkinson's disease	0.00011	0.00371	CbGpPWpGaD
Atazanavir—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00011	0.0037	CbGpPWpGaD
Atazanavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000108	0.00366	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NDUFB11—Parkinson's disease	0.000108	0.00364	CbGpPWpGaD
Atazanavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000107	0.00361	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000104	0.00351	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GCH1—Parkinson's disease	0.000103	0.00347	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MCCC1—Parkinson's disease	0.000102	0.00345	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	9.94e-05	0.00336	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	9.6e-05	0.00324	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TALDO1—Parkinson's disease	9.6e-05	0.00324	CbGpPWpGaD
Atazanavir—ABCC1—Disease—OMD—Parkinson's disease	9.6e-05	0.00324	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	9.29e-05	0.00314	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	9.28e-05	0.00313	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—FBP1—Parkinson's disease	9.17e-05	0.00309	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—DBH—Parkinson's disease	9.17e-05	0.00309	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GBA—Parkinson's disease	9.17e-05	0.00309	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.08e-05	0.00307	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	8.78e-05	0.00296	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.63e-05	0.00292	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ND3—Parkinson's disease	8.55e-05	0.00289	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MCCC1—Parkinson's disease	8.55e-05	0.00289	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—OMD—Parkinson's disease	8.04e-05	0.00271	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TALDO1—Parkinson's disease	8.04e-05	0.00271	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.01e-05	0.0027	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—CP—Parkinson's disease	7.95e-05	0.00268	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.74e-05	0.00261	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.74e-05	0.00261	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TAF1—Parkinson's disease	7.74e-05	0.00261	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FBP1—Parkinson's disease	7.74e-05	0.00261	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	7.73e-05	0.00261	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	7.7e-05	0.0026	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.69e-05	0.0026	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.63e-05	0.00257	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NDUFB11—Parkinson's disease	7.62e-05	0.00257	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	7.59e-05	0.00256	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GCH1—Parkinson's disease	7.27e-05	0.00245	CbGpPWpGaD
Atazanavir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	7.22e-05	0.00244	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	7.07e-05	0.00239	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.97e-05	0.00236	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	6.86e-05	0.00232	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—DDC—Parkinson's disease	6.73e-05	0.00227	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.68e-05	0.00226	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.56e-05	0.00221	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—DBH—Parkinson's disease	6.48e-05	0.00219	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GBA—Parkinson's disease	6.48e-05	0.00219	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—FBP1—Parkinson's disease	6.48e-05	0.00219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.47e-05	0.00218	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.42e-05	0.00217	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTA4—Parkinson's disease	6.35e-05	0.00215	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.27e-05	0.00212	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPL6—Parkinson's disease	6.19e-05	0.00209	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SNCA—Parkinson's disease	6.19e-05	0.00209	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—COMT—Parkinson's disease	5.86e-05	0.00198	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	5.83e-05	0.00197	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	5.82e-05	0.00196	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	5.78e-05	0.00195	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	5.75e-05	0.00194	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PLA2G6—Parkinson's disease	5.72e-05	0.00193	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MAOB—Parkinson's disease	5.66e-05	0.00191	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.66e-05	0.00191	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	5.61e-05	0.00189	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	5.61e-05	0.00189	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	5.59e-05	0.00189	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	5.53e-05	0.00187	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.44e-05	0.00184	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.39e-05	0.00182	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	5.36e-05	0.00181	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	5.29e-05	0.00178	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	5.1e-05	0.00172	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.03e-05	0.0017	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	4.9e-05	0.00166	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—DDC—Parkinson's disease	4.76e-05	0.00161	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.73e-05	0.0016	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPL23A—Parkinson's disease	4.69e-05	0.00158	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPL14—Parkinson's disease	4.69e-05	0.00158	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.66e-05	0.00157	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.6e-05	0.00155	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.54e-05	0.00153	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTA4—Parkinson's disease	4.49e-05	0.00152	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.43e-05	0.0015	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF20—Parkinson's disease	4.37e-05	0.00148	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RPS8—Parkinson's disease	4.37e-05	0.00148	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2D6—Parkinson's disease	4.21e-05	0.00142	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CTGF—Parkinson's disease	4.13e-05	0.00139	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.11e-05	0.00139	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TNF—Parkinson's disease	4.07e-05	0.00137	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MCCC1—Parkinson's disease	4.07e-05	0.00137	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ND3—Parkinson's disease	4.07e-05	0.00137	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PLA2G6—Parkinson's disease	4.04e-05	0.00137	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.04e-05	0.00136	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MAOB—Parkinson's disease	4e-05	0.00135	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.86e-05	0.0013	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2E1—Parkinson's disease	3.85e-05	0.0013	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.85e-05	0.0013	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.84e-05	0.0013	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—OMD—Parkinson's disease	3.82e-05	0.00129	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TALDO1—Parkinson's disease	3.82e-05	0.00129	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.81e-05	0.00129	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.81e-05	0.00129	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NQO1—Parkinson's disease	3.81e-05	0.00129	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ND3—Parkinson's disease	3.8e-05	0.00128	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MCCC1—Parkinson's disease	3.8e-05	0.00128	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.79e-05	0.00128	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.78e-05	0.00128	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TH—Parkinson's disease	3.75e-05	0.00127	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NDUFB11—Parkinson's disease	3.63e-05	0.00122	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYCS—Parkinson's disease	3.6e-05	0.00122	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.57e-05	0.00121	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—OMD—Parkinson's disease	3.57e-05	0.00121	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.53e-05	0.00119	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.49e-05	0.00118	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCH1—Parkinson's disease	3.46e-05	0.00117	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.39e-05	0.00114	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.23e-05	0.00109	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ADRBK1—Parkinson's disease	3.21e-05	0.00108	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HSPA1A—Parkinson's disease	3.19e-05	0.00108	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—COMT—Parkinson's disease	3.19e-05	0.00108	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTP1—Parkinson's disease	3.17e-05	0.00107	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MAOA—Parkinson's disease	3.17e-05	0.00107	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMOX1—Parkinson's disease	3.13e-05	0.00106	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—DBH—Parkinson's disease	3.08e-05	0.00104	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GBA—Parkinson's disease	3.08e-05	0.00104	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—FBP1—Parkinson's disease	3.08e-05	0.00104	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ABCB1—Parkinson's disease	3e-05	0.00101	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2D6—Parkinson's disease	2.98e-05	0.001	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CTGF—Parkinson's disease	2.92e-05	0.000986	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTM1—Parkinson's disease	2.92e-05	0.000985	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.91e-05	0.000984	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.88e-05	0.000972	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—DBH—Parkinson's disease	2.88e-05	0.000972	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GBA—Parkinson's disease	2.88e-05	0.000972	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GPX1—Parkinson's disease	2.79e-05	0.000943	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.76e-05	0.000932	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2E1—Parkinson's disease	2.72e-05	0.000919	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.69e-05	0.000909	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NQO1—Parkinson's disease	2.69e-05	0.000909	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TH—Parkinson's disease	2.65e-05	0.000895	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.59e-05	0.000873	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MTHFR—Parkinson's disease	2.58e-05	0.00087	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYCS—Parkinson's disease	2.55e-05	0.00086	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.54e-05	0.000857	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ND3—Parkinson's disease	2.51e-05	0.000846	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.51e-05	0.000846	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOE—Parkinson's disease	2.4e-05	0.00081	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—OMD—Parkinson's disease	2.36e-05	0.000796	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.36e-05	0.000796	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—DDC—Parkinson's disease	2.26e-05	0.000764	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—COMT—Parkinson's disease	2.25e-05	0.000761	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.25e-05	0.000759	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—Parkinson's disease	2.24e-05	0.000758	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MAOA—Parkinson's disease	2.24e-05	0.000756	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.23e-05	0.000754	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMOX1—Parkinson's disease	2.21e-05	0.000747	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTHFR—Parkinson's disease	2.18e-05	0.000735	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.14e-05	0.000721	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.13e-05	0.00072	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—Parkinson's disease	2.12e-05	0.000717	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—DDC—Parkinson's disease	2.11e-05	0.000714	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—Parkinson's disease	2.06e-05	0.000696	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—INS—Parkinson's disease	2.05e-05	0.000692	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOE—Parkinson's disease	2.03e-05	0.000684	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.01e-05	0.000678	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2e-05	0.000674	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPX1—Parkinson's disease	1.97e-05	0.000667	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.97e-05	0.000665	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.92e-05	0.00065	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MAOB—Parkinson's disease	1.9e-05	0.000643	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GBA—Parkinson's disease	1.9e-05	0.000641	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DBH—Parkinson's disease	1.9e-05	0.000641	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.9e-05	0.000641	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—Parkinson's disease	1.82e-05	0.000615	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.8e-05	0.000607	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.78e-05	0.000601	CbGpPWpGaD
Atazanavir—ABCC1—Disease—INS—Parkinson's disease	1.73e-05	0.000584	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOE—Parkinson's disease	1.7e-05	0.000573	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.69e-05	0.000572	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—INS—Parkinson's disease	1.45e-05	0.000489	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.42e-05	0.000478	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DDC—Parkinson's disease	1.39e-05	0.000471	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CTGF—Parkinson's disease	1.39e-05	0.000469	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.32e-05	0.000446	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.32e-05	0.000445	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.3e-05	0.000438	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.29e-05	0.000437	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NQO1—Parkinson's disease	1.28e-05	0.000432	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TH—Parkinson's disease	1.26e-05	0.000426	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYCS—Parkinson's disease	1.21e-05	0.000409	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.21e-05	0.000408	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.2e-05	0.000404	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.19e-05	0.0004	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TH—Parkinson's disease	1.18e-05	0.000398	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.17e-05	0.000396	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.13e-05	0.000382	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—COMT—Parkinson's disease	1.07e-05	0.000362	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.07e-05	0.00036	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MAOA—Parkinson's disease	1.07e-05	0.00036	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.05e-05	0.000356	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—COMT—Parkinson's disease	1e-05	0.000338	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.97e-06	0.000337	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.95e-06	0.000336	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.84e-06	0.000332	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—Parkinson's disease	9.81e-06	0.000331	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.44e-06	0.000319	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—Parkinson's disease	9.4e-06	0.000317	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.17e-06	0.000309	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.78e-06	0.000296	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.72e-06	0.000294	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—Parkinson's disease	8.67e-06	0.000293	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.56e-06	0.000289	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.1e-06	0.000274	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOE—Parkinson's disease	8.07e-06	0.000273	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.98e-06	0.000269	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.89e-06	0.000266	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TH—Parkinson's disease	7.77e-06	0.000262	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—Parkinson's disease	7.56e-06	0.000255	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOE—Parkinson's disease	7.54e-06	0.000255	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.46e-06	0.000252	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—INS—Parkinson's disease	6.9e-06	0.000233	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COMT—Parkinson's disease	6.61e-06	0.000223	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.58e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.56e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.49e-06	0.000219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—INS—Parkinson's disease	6.44e-06	0.000218	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.23e-06	0.00021	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.04e-06	0.000204	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.79e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.34e-06	0.00018	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOE—Parkinson's disease	4.97e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—INS—Parkinson's disease	4.25e-06	0.000143	CbGpPWpGaD
